COMBINATION OF NITROUS OXIDE AND 5-HT2A RECEPTOR AGONISTS Application WO-2023186963-A1 World Intellectual Property Organisation (WIPO) 05 Oct 2023
Pharmaceutically acceptable salts and compositions thereof Grant US-11773063-B1 United States of America 03 Oct 2023
Crystalline 5-methoxy-n,n-diallyltryptamine compounds Grant US-11739060-B2 United States of America 29 Aug 2023
Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine Grant US-11680044-B2 United States of America 20 Jun 2023
COMBINATION DRUG THERAPIES Application WO-2023036473-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine Grant US-11603353-B2 United States of America 14 Mar 2023
Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine Grant US-11518742-B2 United States of America 06 Dec 2022
Pharmaceutical composition comprising 5-methoxy-N,N-dimethyltryptamine Grant US-11518743-B2 United States of America 06 Dec 2022
5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION Application WO-2020169850-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020